High Cholesterol News and Research

RSS

Link between high cholesterol and better memory

What's bad for your ticker may be good for your bean, according to a research from a team of scientists at Boston University.

22 Mar 2005

Link between C-reactive protein, heart disease and stroke

The cells that line the arteries are able to produce C-reactive protein, according to a study funded by the National Institutes of Health and published in the April issue of American Journal of Pathology.

16 Mar 2005

New insight into key mechanism by which cells limit cholesterol

The finding suggests a novel approach to the development of cholesterol-lowering drugs that may boost the effect of statins, one of the most prescribed cholesterol inhibitors, according to researchers at the University of Texas Southwestern Medical Center.

15 Mar 2005

Mainstream model of medical care may not be the answer for eliminating disparities in African American population

Having a health clinic in the apartment next door may not be everyone's idea of a good neighbor. But a new study shows that such a clinic can be much more effective than a traditional one in improving African American's heart health.

15 Mar 2005

Obesity among African-American stroke survivors increases risk factors for recurrent stroke

Obesity may put African-Americans who have survived one stroke at risk for a second stroke by increasing their risk of hypertension (high blood pressure), diabetes and high cholesterol, according to an article in the March issue of Archives of Neurology, one of the JAMA/Archives journals.

14 Mar 2005

Growth hormone treatment may reduce serious metabolic conditions

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

14 Mar 2005

Gene identified that confers susceptibility to age-related macular degeneration

By combining the tools of high-throughput biology and statistical genetics, scientists at Rockefeller University, Yale University School of Public Health and the National Eye Institute have identified a gene that confers susceptibility to age-related macular degeneration (AMD), the most common cause of vision loss in the United Sates for those over 60.

14 Mar 2005

HIV is not an independent risk factor for severe heart disease

Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).

8 Mar 2005

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

8 Mar 2005

Aspirin does not prevent first heart attacks or death from cardiovascular causes in women

The Women's Health Study is the first large clinical trial to study the use of low-dose aspirin to prevent heart attack and stroke in women.

7 Mar 2005

People who live with migraine headaches show a riskier profile for cardiovascular disease

People who live with migraine headaches show a "riskier" profile for cardiovascular disease than those without migraines, according to a new study published in the February 22 issue of Neurology, the scientific journal of the American Academy of Neurology.

22 Feb 2005

82 percent of women have at least one factor that puts them at risk for a future heart attack

In the second year of a Northern California-based survey conducted by Sutter Health on women and heart disease, results show that more women are aware of heart attack warning signs and the need to take action quickly.

21 Feb 2005

Prozac, Xenical and Meridia may help type 2 diabetes patients lose weight

Three commonly used drugs - Prozac, Xenical and Meridia - may help type 2 diabetes patients lose small amounts of weight, although long-term benefits are not clear, a new review of 22 studies suggests.

20 Feb 2005

Ground-breaking trial to test best program for obese children

More than 100 overweight young children from the New South Wales, Illawarra region are being sought to participate in one of the first randomised controlled trials of its kind in Australia that will help determine how best to tackle their obesity problem.

17 Feb 2005

Researchers find way to produce cholesterol-lowering snack chips

Brandeis University biology professor K.C. Hayes and Senior Research Associate Andy Pronczuk at the school's Foster Biomedical Research Laboratory, and Senior Scientist Daniel Perlman in the Physics Department have discovered a way to produce chips and other snack foods that can actually lower your cholesterol while you eat them - without having any impact on taste

8 Feb 2005

Rheumatoid arthritis linked to excess risk of congestive heart failure

A serious chronic disease, rheumatoid arthritis (RA) is characterized by inflammation and damage of the joint, major organ involvement and increased mortality. Among patients, about one in three deaths results from cardiovascular disease (conditions affecting the heart or blood vessels).

3 Feb 2005

High cholesterol, hypertension, diabetes and smoking may increase risk of dementia

High cholesterol, hypertension, diabetes and smoking have long been considered -- and aggressively treated -- as risk factors for cardiovascular disease.

25 Jan 2005

Role of ethnicity in nonalcoholic fatty liver disease

The first study to examine nonalcoholic fatty liver disease (NAFLD) among different ethnic and racial groups in the United States finds that Hispanics may be at a higher risk of developing the condition. The study is published in Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience.

19 Jan 2005

No to over the counter statin!

Last Friday an FDA expert panel voted overwhelmingly against the over-the-counter sale of Merck's cholesterol lowering drug Mevacor (lovastatin). Mevacor is one of a number of drugs known as "statins" which are widely considered to be the most effective drugs for the treatment of high cholesterol. Statins work by inhibiting a liver enzyme used in the manufacture of cholesterol.

17 Jan 2005

Weight, fitness and lifestyle are important factors contributing to metabolic syndrome

The metabolic syndrome, a group of several abnormalities, including obesity and high blood pressure, in one individual was identified in 10.4 percent of 36-year-old study participants, according to an article in the January 10 issue of Archives of Internal Medicine.

10 Jan 2005

High Cholesterol News and Research

Link between high cholesterol and better memory

Link between C-reactive protein, heart disease and stroke

New insight into key mechanism by which cells limit cholesterol

Mainstream model of medical care may not be the answer for eliminating disparities in African American population

Obesity among African-American stroke survivors increases risk factors for recurrent stroke

Growth hormone treatment may reduce serious metabolic conditions

Gene identified that confers susceptibility to age-related macular degeneration

HIV is not an independent risk factor for severe heart disease

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Aspirin does not prevent first heart attacks or death from cardiovascular causes in women

People who live with migraine headaches show a riskier profile for cardiovascular disease

82 percent of women have at least one factor that puts them at risk for a future heart attack

Prozac, Xenical and Meridia may help type 2 diabetes patients lose weight

Ground-breaking trial to test best program for obese children

Researchers find way to produce cholesterol-lowering snack chips

Rheumatoid arthritis linked to excess risk of congestive heart failure

High cholesterol, hypertension, diabetes and smoking may increase risk of dementia

Role of ethnicity in nonalcoholic fatty liver disease

No to over the counter statin!

Weight, fitness and lifestyle are important factors contributing to metabolic syndrome

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News